Constant Therapeutics
PrivateLast Round
Grant
Feb 28, 2019
Total Funding Raised
$2.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Constant Therapeutics is a biopharmaceutical company developing proprietary peptides and small molecules for the treatment of stroke recovery, rare neuromuscular disorders, and connective tissue diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Constant Therapeutics Comparables
Compare Constant Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProNeurogen, Inc. | 89% | |
| US Biotest, Inc. | 81% | |
| Alevian, Inc. | 76% | |
Constant Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 28, 2019 |
Constant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EB Research Partnership | Grant |
| LifeArc | Grant |
| DEBRA Research gGmbH | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors grew 96% MoM.
- May 20, 2026
Monthly visitors increased 2061% MoM, from 38 to 821.
Constant Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Constant Therapeutics's valuation, stock price, and market status.